Speaker

Dr. Youngjin Park is the President of Obliv Clinic Network in Incheon, Seoul, and Bangkok, and serves as the Chief International Academic Director for both the Korean Aesthetic Surgery & Laser Society (ASLS/DEMIRE) and the Korean Academy of Facelifting and Contouring (KAFC). He is also an AMWC 2026 Jury member.

A graduate of Inha University College of Medicine, Dr. Park completed an executive program at Seoul National University and previously served as a Public Doctor for the Korean Government. His clinical expertise includes facial rejuvenation using HA, CaHA, PLLA, PDLLA, PCL, and polynucleotides (PN), thread lifting and SMAS anatomy, energy-based aesthetic devices, and regenerative aesthetic medicine involving exosomes and biomaterials.

Dr. Park is an internationally recognized Global KOL, trainer, and academic advisor for leading aesthetic companies including Wontech, Merz, Dexlevo, Humedix, Jetema, Sacci Bio, and Juvelook. He is widely known for his expertise in minimally invasive facial rejuvenation, regenerative injectables, thread lifting, and skin quality enhancement.

He is a frequent speaker and hands-on trainer at major international congresses such as AMWC Monaco, IMCAS Paris and Asia, ASLS Seoul and Bangkok, MEVOS Xi’an, WCAM, and AMSC Malaysia. His lectures focus on regenerative medicine, filler safety, PDO thread technologies, and advanced biomaterial delivery systems.

Dr. Park has also published extensively in peer-reviewed journals including Antioxidants, Diagnostics, Polymers, Journal of Cosmetic Dermatology, and International Journal of Molecular Sciences. His research covers exosome therapy, facial filler safety, botulinum toxin techniques, biomaterials, and advanced dermal filler technologies.